Ibogaine: Difference between revisions
| [pending revision] | [pending revision] |
MDElliottMD (talk | contribs) Tier 2 taxonomy consolidation: merge Classic Psychedelics into Classical Psychedelics (Serotonergic) |
MDElliottMD (talk | contribs) Category taxonomy ship: retag Addiction Medicine -> Anti-addiction agents |
||
| Line 42: | Line 42: | ||
[[Category:Κ-Opioid Receptor Agonists]] | [[Category:Κ-Opioid Receptor Agonists]] | ||
[[Category:NMDA Receptor Antagonists]] | [[Category:NMDA Receptor Antagonists]] | ||
[[Category: | [[Category:Anti-addiction agents]] | ||
Revision as of 00:36, 22 May 2026
Psychedelic, Dissociative
Ibogaine
Experience
No personal reports yet
No clinical reports yet
Log in to add your own experience.
Problems
No problems yet. Be the first to suggest one.
+ Add a problemTitration strategies
No titration strategies yet. Be the first to suggest one.
Effects
No effects listed yet. Be the first to suggest one.
Interactions
No interactions reported yet.
Relevant anecdote
No anecdotes yet. Share a relevant one.
Relevant Literature
No literature entries yet.
Log in to submit relevant literature.
Summary
Classes
Psychedelic, Dissociative
Common uses
Pharmacy
Pharmacology
Purported mechanism
Kappa-opioid agonist; NMDA antagonist; SERT/DAT/NET inhibitor
“Pendell's corner
Iboga's alkaloid in pure form does what the root bark does, but it does it pharmaceutically, in milligram doses, in clinics that bill insurance. The Bwiti gave the world the Ally; the pharmacologists gave the world the molecule; the question of how to give people the initiation without the village remains open.
— Dale Pendell, Pharmako/Gnosis
curated paraphrase — replace with verbatim passage
curated paraphrase — replace with verbatim passage